Your browser doesn't support javascript.
loading
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.
Fabiani, Claudia; Vitale, Antonio; Emmi, Giacomo; Bitossi, Alice; Lopalco, Giuseppe; Sota, Jurgen; Guerriero, Silvana; Orlando, Ida; Capozzoli, Marco; Fusco, Fiorella; Rana, Francesco; Iannone, Florenzo; Frediani, Bruno; Galeazzi, Mauro; Vannozzi, Lorenzo; Tosi, Gian Marco; Cantarini, Luca.
Afiliação
  • Fabiani C; Department of Ophthalmology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy. claudia.fabiani@gmail.com.
  • Vitale A; Ophthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy. claudia.fabiani@gmail.com.
  • Emmi G; Research Center of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
  • Bitossi A; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Lopalco G; Department of Surgery and Translational Medicine, Eye Clinic, University of Florence, Florence, Italy.
  • Sota J; Interdisciplinary Department of Medicine, Rheumatology Unit, University of Bari, Bari, Italy.
  • Guerriero S; Research Center of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
  • Orlando I; Department of Ophthalmology and Otolaryngology, University of Bari, Bari, Italy.
  • Capozzoli M; Research Center of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
  • Fusco F; Ophthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Rana F; Ophthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Iannone F; Ophthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
  • Frediani B; Interdisciplinary Department of Medicine, Rheumatology Unit, University of Bari, Bari, Italy.
  • Galeazzi M; Research Center of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
  • Vannozzi L; Research Center of Systemic Autoinflammatory Diseases, Behçet's Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy.
  • Tosi GM; Department of Surgery and Translational Medicine, Eye Clinic, University of Florence, Florence, Italy.
  • Cantarini L; Ophthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Clin Rheumatol ; 38(1): 63-70, 2019 Jan.
Article em En | MEDLINE | ID: mdl-29611087
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uveíte / Fator de Necrose Tumoral alfa / Antirreumáticos / Adalimumab / Infliximab Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uveíte / Fator de Necrose Tumoral alfa / Antirreumáticos / Adalimumab / Infliximab Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Clin Rheumatol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Itália País de publicação: Alemanha